Analytical Data
-
Gene name
ATPBD4
- Application
-
Alternative Names
DPH6; ATPBD4Diphthine--ammonia ligase; EC 6.3.1.14; ATP-binding domain-containing Protein 4
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7L8W6
-
Expression Region
1-267aa
-
AA Sequence
MRVAALISGG KDSCYNMMQC IAAGHQIVAL ANLRPAENQV GSDELDSYMY QTVGHHAIDL YAEAMALPLY RRTIRGRSLD TRQVYTKCEG DEVEDLYELL KLVKEKEEVE GISVGAILSD YQRIRVENVC KRLNLQPLAY LWQRNQEDLL REMISSNIQA MIIKVAALGL DPDKHLGKTL DQMEPYLIEL SKKYGVHVCG EGGEYETFTL DCPLFKKKII VDSSEVVIHS ADAFAPVAYL RFLELHLEDK VSSVPDNYRT SNYIYNF
-
Molecular Weight
267 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ATPBD4, a member of the ATP-binding cassette (ABC) transporter family, has gained attention due to its potential role in various biological processes and diseases. Research has shown that ATPBD4 is involved in mitochondrial dynamics and cellular bioenergetics, suggesting its importance in maintaining cellular function and homeostasis. Its expression has been linked to response mechanisms in cancer, highlighting its potential as a therapeutic target. Given these implications, recombinant ATPBD4 protein is produced for in-depth studies, enabling researchers to investigate its structural properties, interaction with other cellular components, and functional roles in health and disease. Understanding the biochemical mechanisms of ATPBD4 can unravel novel insights into its regulation and contribution to cellular processes, paving the way for potential applications in disease treatment and management. Overall, the study of ATPBD4 not only enhances our comprehension of ABC transporters but also aids in the exploration of new avenues for therapeutic intervention in disorders where ATPBD4 is implicated.











